NCT04328844 2026-03-30A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersiOncturaPhase 1 Active not recruiting210 enrolled
NCT03013218 2025-08-01A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)ALX Oncology Inc.Phase 1 Completed174 enrolled
NCT02750670 2025-06-22Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin LymphomaUniversity Health Network, TorontoPhase 2 Completed30 enrolled